KLK3 and prostate cancer: The Prostate Cancer Prevention Trial included 18 882 cis men, and 15% of those with a PSA <4 ng/mL (the reference range used), were found on biopsy to have prostate cancer, of which 15% had advanced disease (Gleason Score >7) [8].